Issue link: https://viewer.e-digitaledition.com/i/298497
C HARIS ENG, MD, PhD, FACP, Chair and Founder of Lerner Research Institute's Genomic Medicine Institute and its clinical arm the Center for Personalized Healthcare, was recently honored by three national medical associations: the Society of Surgical Oncology (SSO), the American Association for Cancer Research (AACR), and the American Medical Women's Association (AMWA). In March, Dr. Eng gave the James Ewing Memorial Keynote Lecture at the SSO Annual Meeting in Phoenix, Ariz. The James Ewing Lecture is the highest award of the SSO given to a physician whose work has had a major impact on surgical oncology. Dr. Ewing was a Professor of Pathology at Cornell University and Memorial Hospital in New York whose is widely regarded as "the Father of Oncology." In April at the AACR Annual Meeting in San Diego CA, Dr. Eng was awarded the 17th Annual AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship. This honor recognized her meritorious contributions to the field of cancer research and unstinting support and active promotion of women working in cancer research, medicine, and genetics. Also at the AACR Annual Meeting, Dr. Eng was honored with the AMWA's Exceptional Mentor Award for her impact on female physicians' lives, careers and patients. Dr. Eng is one of two clinical physicians ranked on a list of the most of influential scientists published in the European Journal of Clinical Investigation, October 2013. The list ranks the top 400 most influential sci- entists in biological medicine (all fields) according to the number of publications from 1996–2011. Dr. Eng was ranked 61st with 20,202 citations. Her work has been published in more than 400 peer- reviewed publications. Dr. Eng's important research discoveries include the identification, characterization, and understanding of genes that cause susceptibility to inherited cancer syndromes and the determination of how these genes can be used to develop new clinical applications. She was the founding chair of the International Cowden Consortium, which mapped and identified the PTEN tumor suppressor gene as the susceptibil- ity gene for Cowden syndrome. And her laboratory continues to investigate the ways in which PTEN inactivation occurs in different cancers and to look for novel approaches to targeting it for therapy and prevention. Throughout her career, Dr. Eng has received numerous national awards, includ- ing the Doris Duke Clinical Scientist Award and the American Cancer Society Clinical Research Professorship. She was also elected to the Institute of Medicine of the National Academies, the American Society of Clinical Investigation, and the American Association of Physicians. In 2009, she was appointed to the Advisory Committee on Genetics, Health, and Society by U.S. Health and Human Services Secretary Kathleen Sebelius. ■ Honored by Three National Associations Dr. Charis Eng 1 6 | Cleveland/Akron/Canton MD NEWS ■ M D N E W S . CO M ■ M AY/J U N E 2 0 1 4